Expected to drive market expansion in the near future at a CAGR of 5.80% during the forecast period 2023 to 2032

Market Research Future (MRFR) has published a “Global Interventional Radiology Products Market” 

Market Highlights

The global interventional radiology products market is accounted to register a CAGR of 5.80% during the forecast period and is estimated to reach USD 42.0 Billion by 2032.

Interventional radiology is focused on diagnosing and treating patients with the least amount of invasiveness possible. MRI, CT, fluoroscopy, and other modalities are some of the radiological guidance systems and apparatus utilized in this field of medicine. These techniques are mostly used in interventional radiological procedures for the diagnosis of any underlying ailments that the patient may have that can be shown in images. Vascular and interventional radiology (VIR) is another name for interventional radiology.

The advantages of minimally invasive procedures over conventional open surgery methods have increased demand for them. The American Institute of Minimally Invasive Surgery (AIMS) lists improved safety, reduced scarring, speedier recovery, and shorter hospital stays as benefits of minimally invasive procedures over conventional open surgery techniques. Minimally invasive procedures are becoming more and more popular as a result of the rising use of technologically advanced products and methods, particularly in the treatment of cancer, cardiovascular disease (CVD), and peripheral artery disease (PAD). The market for interventional radiology products is projected to benefit from this.

Key Players:

MRFR recognizes the following companies as the key players in the global interventional radiology products market— Boston Scientific Corporation, Abbott, Cardinal Health, Cook, Stryker, B. Braun Melsungen AG, Terumo Corporation, General Electric, Koninklijke Philips N.V., Carestream Health, ESAOTE SPA, Hitachi, Ltd., Hologic, Inc., Shimadzu Corporation, Siemens Healthcare GmbH, CANON MEDICAL SYSTEMS CORPORATION, Samsung Medison Co., Ltd., Medtronic, Agfa-Gevaert Group, Teleflex Incorporated, Analogic Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Trivitron Healthcare, Toshiba International Corporation, and FUJIFILM Holdings Corporation, among others.

Segment Analysis

The global interventional radiology products market has been segmented into type, application and end user.

On the basis of type, the market is segmented into stents, catheters, inferior vena cava (IVC) filters, embolization devices, thrombectomy systems, angioplasty balloons, biopsy needles, hemodynamic flow alteration devices, accessories, other. The accessories segment was attributed to holding the largest market share in 2022.

Based on application, the global interventional radiology products market has been segmented into cardiology, oncology, gastroenterology, neurology, orthopedics, urology & nephrology, and others. The Cardiology segment was expected to hold the largest market share in 2022.

Based on end user, the global interventional radiology products market has been segmented into hospitals, clinics, and home care settings. The hospitals segment was expected to hold the largest market share in 2022.

Explore In-depth Details: Interventional Radiology Products Market Research Report

Regional Analysis

The global interventional radiology products market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe interventional radiology products market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The interventional radiology products market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World interventional radiology products market comprises of Middle East, Africa, and Latin America.

The largest market share for interventional radiology products was maintained by the North American regional sector. The reason for this is that the area has a strong healthcare infrastructure and numerous important key stakeholders.

Moreover, the Europe held the second largest share for the market. The market growth in this region is primarily driven by the presence of a well-established healthcare infrastructure, favorable reimbursement policies, and the availability of highly skilled interventional radiologists.

Additionally, the APAC region is expected to grow at a higher CAGR due to the increasing awareness of minimally invasive procedures, the rising demand for interventional radiology products, and the growing adoption of advanced medical technologies in emerging countries such as China and India.

Furthermore, the LATEM region is expected to witness significant growth due to the increasing prevalence of chronic diseases, the rising demand for minimally invasive procedures, and the growing healthcare expenditure in countries such as Brazil and Mexico. Also, The MEA region is expected to grow at a slower pace than other regions due to the limited availability of interventional radiology products, the lack of skilled healthcare professionals, and the low healthcare expenditure in some countries.

Key Findings of the Study

• The global interventional radiology products market is expected to reach USD 42.0 Billion by 2032, at a CAGR of 5.80% during the forecast period.


• The Asia Pacific region accounted for the fastest-growing global market due to area has a strong healthcare infrastructure and numerous important key stakeholders


• Based on type, the accessories segment was attributed to holding the largest market in 2022, with an approximate market share of 36.98%.


• Boston Scientific Corporation, Abbott, Cardinal Health, Cook, Stryker, B. Braun Melsungen AG, Terumo Corporation, General Electric, Koninklijke Philips N.V., Carestream Health, ESAOTE SPA, Hitachi, Ltd., Hologic, Inc., Shimadzu Corporation, Siemens Healthcare GmbH, CANON MEDICAL SYSTEMS CORPORATION, Samsung Medison Co., Ltd., Medtronic, Agfa-Gevaert Group, Teleflex Incorporated, Analogic Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Trivitron Healthcare, Toshiba International Corporation, and FUJIFILM Holdings Corporation, among others.